Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
275.08 USD | -0.04% |
|
-0.59% | +18.45% |
10/07 | Deutsche Bank Adjusts Price Target on CME Group to $273 From $266, Maintains Hold Rating | MT |
10/07 | Sector Update: Financial Stocks Decline Premarket Thursday | MT |
Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 1.67 | 1.01 | 1.01 | 1.42 | 1.84 | |||||
Return on Total Capital | 5.48 | 5.26 | 6.03 | 7.03 | 8.08 | |||||
Return On Equity % | 8.02 | 9.81 | 9.92 | 12.03 | 13.25 | |||||
Return on Common Equity | 8.03 | 9.74 | 9.79 | 11.88 | 13.08 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 100 | 100 | 100 | 100 | 100 | |||||
SG&A Margin | 31.99 | 31.67 | 29.08 | 28.19 | 26.89 | |||||
EBITDA Margin % | 64.43 | 63.9 | 67.19 | 68.43 | 69.82 | |||||
EBITA Margin % | 61.28 | 60.74 | 64.49 | 66.17 | 67.94 | |||||
EBIT Margin % | 54.89 | 55.66 | 59.95 | 62.1 | 64.32 | |||||
Income From Continuing Operations Margin % | 43.25 | 56.35 | 53.73 | 57.93 | 57.61 | |||||
Net Income Margin % | 43.23 | 56.34 | 53.73 | 57.93 | 57.61 | |||||
Net Avail. For Common Margin % | 43.23 | 55.93 | 53.05 | 57.2 | 56.88 | |||||
Normalized Net Income Margin | 35.25 | 39.29 | 43.55 | 46.61 | 46.28 | |||||
Levered Free Cash Flow Margin | 40.8 | 43.68 | 53.94 | 46.07 | 43.8 | |||||
Unlevered Free Cash Flow Margin | 42.93 | 45.91 | 55.98 | 47.86 | 45.44 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.05 | 0.03 | 0.03 | 0.04 | 0.05 | |||||
Fixed Assets Turnover | 4.6 | 4.7 | 5.66 | 7.04 | 8.65 | |||||
Receivables Turnover (Average Receivables) | 9.32 | 9.69 | 10.36 | 10.31 | 10.28 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.01 | 1.01 | 1.01 | 1.02 | 1.01 | |||||
Quick Ratio | 0.02 | 0.02 | 0.02 | 0.04 | 0.03 | |||||
Operating Cash Flow to Current Liabilities | 0.03 | 0.01 | 0.02 | 0.04 | 0.04 | |||||
Days Sales Outstanding (Average Receivables) | 39.26 | 37.65 | 35.23 | 35.4 | 35.6 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 15.45 | 14.69 | 14.69 | 14.53 | 14.43 | |||||
Total Debt / Total Capital | 13.38 | 12.81 | 12.81 | 12.68 | 12.61 | |||||
LT Debt/Equity | 15.25 | 11.76 | 14.41 | 14.32 | 11.4 | |||||
Long-Term Debt / Total Capital | 13.21 | 10.25 | 12.57 | 12.5 | 9.96 | |||||
Total Liabilities / Total Assets | 78.86 | 86.08 | 84.57 | 79.39 | 80.73 | |||||
EBIT / Interest Expense | 16.09 | 15.61 | 18.46 | 21.7 | 24.47 | |||||
EBITDA / Interest Expense | 19.2 | 18.23 | 20.97 | 24.19 | 26.82 | |||||
(EBITDA - Capex) / Interest Expense | 18.01 | 17.47 | 20.42 | 23.72 | 26.24 | |||||
Total Debt / EBITDA | 1.28 | 1.32 | 1.16 | 1.01 | 0.89 | |||||
Net Debt / EBITDA | 0.73 | 0.35 | 0.33 | 0.22 | 0.19 | |||||
Total Debt / (EBITDA - Capex) | 1.36 | 1.38 | 1.19 | 1.03 | 0.91 | |||||
Net Debt / (EBITDA - Capex) | 0.78 | 0.37 | 0.34 | 0.23 | 0.19 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 0.26 | -3.92 | 9.74 | 11.19 | 9.9 | |||||
Gross Profit, 1 Yr. Growth % | 0.26 | -3.92 | 9.74 | 11.19 | 9.9 | |||||
EBITDA, 1 Yr. Growth % | 0.27 | -4.71 | 17.06 | 13.24 | 12.14 | |||||
EBITA, 1 Yr. Growth % | 0.46 | -4.77 | 18.46 | 14.07 | 12.85 | |||||
EBIT, 1 Yr. Growth % | 0.65 | -2.58 | 20.62 | 15.17 | 13.83 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | -0.44 | 25.19 | 2.05 | 19.89 | 9.29 | |||||
Net Income, 1 Yr. Growth % | -0.53 | 25.23 | 2.07 | 19.89 | 9.29 | |||||
Normalized Net Income, 1 Yr. Growth % | -0.19 | 7.11 | 23.48 | 19 | 9.11 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | -0.68 | 24.19 | 1.51 | 19.73 | 9.14 | |||||
Accounts Receivable, 1 Yr. Growth % | -6.2 | -5.81 | 11.21 | 10.84 | 7 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | -0.03 | -12.05 | -10.01 | -11.14 | -9.78 | |||||
Total Assets, 1 Yr. Growth % | 65.74 | 57.85 | -11.49 | -25.53 | 5.97 | |||||
Tangible Book Value, 1 Yr. Growth % | -5.6 | -41.16 | 5.55 | -1.63 | 0.35 | |||||
Common Equity, 1 Yr. Growth % | 0.73 | 4.1 | -1.9 | -0.52 | -0.94 | |||||
Cash From Operations, 1 Yr. Growth % | 1.6 | -11.53 | 27.21 | 13.02 | 6.85 | |||||
Capital Expenditures, 1 Yr. Growth % | -19.58 | -35.6 | -29.48 | -14.83 | 23.04 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -7.27 | 2.87 | 37.01 | -5.04 | 4.47 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -7.24 | 2.75 | 35.02 | -4.93 | 4.34 | |||||
Dividend Per Share, 1 Yr. Growth % | 13.33 | 5.88 | 11.11 | 10 | 4.55 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 6.31 | -1.96 | 1.27 | 8.97 | 10.42 | |||||
Gross Profit, 2 Yr. CAGR % | 6.31 | -1.96 | 1.27 | 8.97 | 10.42 | |||||
EBITDA, 2 Yr. CAGR % | 3.49 | -2.25 | 3.56 | 12.9 | 12.69 | |||||
EBITA, 2 Yr. CAGR % | 3.04 | -2.19 | 4.04 | 13.87 | 13.46 | |||||
EBIT, 2 Yr. CAGR % | -0.15 | -0.98 | 5.98 | 15.23 | 14.5 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 3.57 | 11.64 | 13.03 | 10.61 | 14.46 | |||||
Net Income, 2 Yr. CAGR % | 3.58 | 11.61 | 13.06 | 10.62 | 14.46 | |||||
Normalized Net Income, 2 Yr. CAGR % | -0.52 | 3.39 | 12.73 | 18.22 | 13.95 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 1.39 | 11.06 | 12.28 | 10.24 | 14.31 | |||||
Accounts Receivable, 2 Yr. CAGR % | -8.69 | -6.01 | 2.35 | 11.03 | 8.91 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 53.58 | -6.23 | -11.04 | -10.58 | -10.46 | |||||
Total Assets, 2 Yr. CAGR % | 26.85 | 61.75 | 18.2 | -18.81 | -11.17 | |||||
Tangible Book Value, 2 Yr. CAGR % | -7.15 | -25.47 | -21.19 | 1.9 | -0.64 | |||||
Common Equity, 2 Yr. CAGR % | 0.77 | 2.4 | 1.06 | -1.21 | -0.73 | |||||
Cash From Operations, 2 Yr. CAGR % | 5.48 | -5.19 | 6.08 | 19.9 | 9.89 | |||||
Capital Expenditures, 2 Yr. CAGR % | 30.09 | -28.03 | -32.61 | -22.5 | 2.37 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 23.4 | -2.33 | 16.61 | 12.04 | -0.4 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 22.06 | -2.37 | 15.8 | 11.38 | -0.4 | |||||
Dividend Per Share, 2 Yr. CAGR % | 10.19 | 9.54 | 8.47 | 10.55 | 7.24 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 10.14 | 2.78 | 0.96 | 4.48 | 9.28 | |||||
Gross Profit, 3 Yr. CAGR % | 10.14 | 2.78 | 0.96 | 4.48 | 9.28 | |||||
EBITDA, 3 Yr. CAGR % | 7.73 | 0.68 | 2.45 | 6.69 | 12.64 | |||||
EBITA, 3 Yr. CAGR % | 7.59 | 0.36 | 2.83 | 7.28 | 13.53 | |||||
EBIT, 3 Yr. CAGR % | 5.12 | -0.96 | 4.17 | 8.96 | 14.76 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | -19.67 | 10.32 | 8.35 | 15.27 | 10.17 | |||||
Net Income, 3 Yr. CAGR % | -19.68 | 10.35 | 8.33 | 15.29 | 10.17 | |||||
Normalized Net Income, 3 Yr. CAGR % | 2.82 | 1.96 | 8.25 | 14.78 | 15.1 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | -21.08 | 8.48 | 7.78 | 14.71 | 9.88 | |||||
Accounts Receivable, 3 Yr. CAGR % | 8.65 | -7.74 | -0.59 | 5.1 | 9.67 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 38.34 | 27.54 | -7.51 | -11.07 | -10.31 | |||||
Total Assets, 3 Yr. CAGR % | 18.04 | 36.44 | 32.3 | 1.33 | -11.27 | |||||
Tangible Book Value, 3 Yr. CAGR % | 11.69 | -20.25 | -16.31 | -15.15 | 1.38 | |||||
Common Equity, 3 Yr. CAGR % | 5.5 | 1.87 | 0.95 | 0.53 | -1.12 | |||||
Cash From Operations, 3 Yr. CAGR % | 15.75 | -0.53 | 4.57 | 8.35 | 15.38 | |||||
Capital Expenditures, 3 Yr. CAGR % | 34.1 | 2.91 | -28.52 | -27.14 | -9.59 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 11.23 | 16.14 | 8.04 | 8.89 | 9.46 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 11.28 | 15.25 | 7.54 | 8.43 | 8.99 | |||||
Dividend Per Share, 3 Yr. CAGR % | 8.8 | 8.74 | 10.06 | 8.97 | 8.51 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 7.92 | 5.41 | 6.56 | 5.26 | 4.68 | |||||
Gross Profit, 5 Yr. CAGR % | 7.92 | 5.41 | 6.56 | 5.26 | 4.68 | |||||
EBITDA, 5 Yr. CAGR % | 7.08 | 4.08 | 6.04 | 5.4 | 6.43 | |||||
EBITA, 5 Yr. CAGR % | 7.29 | 4.15 | 6.15 | 5.56 | 6.96 | |||||
EBIT, 5 Yr. CAGR % | 5.98 | 3.22 | 5.47 | 5.22 | 8.19 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 11.05 | 11.44 | -7.91 | 10.44 | 10.75 | |||||
Net Income, 5 Yr. CAGR % | 11.04 | 11.44 | -7.91 | 10.46 | 10.75 | |||||
Normalized Net Income, 5 Yr. CAGR % | 6.59 | 5.16 | 6.68 | 8.4 | 10.49 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 9.73 | 9.98 | -9.12 | 9.18 | 10.35 | |||||
Accounts Receivable, 5 Yr. CAGR % | 5.21 | 3.58 | 6.08 | -0.65 | 3.11 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 16.57 | 16.96 | 15.95 | 10.65 | -8.7 | |||||
Total Assets, 5 Yr. CAGR % | 13.1 | 23.19 | 18.11 | 10.86 | 12.81 | |||||
Tangible Book Value, 5 Yr. CAGR % | -0.63 | -10.94 | -2.85 | -12.03 | -10.36 | |||||
Common Equity, 5 Yr. CAGR % | 5.07 | 6.14 | 3.7 | 0.62 | 0.27 | |||||
Cash From Operations, 5 Yr. CAGR % | 12.12 | 6.76 | 11.78 | 7.19 | 6.67 | |||||
Capital Expenditures, 5 Yr. CAGR % | 11.58 | 6.74 | 1.84 | -8.12 | -17.48 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 4.28 | 3.84 | 13.35 | 14.48 | 4.58 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 4.4 | 3.95 | 13.07 | 13.69 | 4.29 | |||||
Dividend Per Share, 5 Yr. CAGR % | 11.2 | 8.45 | 8.67 | 9.46 | 8.92 |
- Stock Market
- Equities
- CME Stock
- Financials CME Group Inc.
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions

MarketScreener is also available in this country: United States.
Switch edition